Microbiota of De-Novo Pediatric IBD : Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis
MetadataShow full item record
Hansen , R , Russell , R K , Reiff , C , Louis , P , McIntosh , F , Berry , S H , Mukhopadhya , I , Bisset , W M , Barclay , A R , Bishop , J , Flynn , D M , McGrogan , P , Loganathan , S , Mahdi , G , Flint , H J , El-Omar , E M & Hold , G L 2012 , ' Microbiota of De-Novo Pediatric IBD : Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis ' American journal of gastroenterology , vol. 107 , no. 12 , pp. 1913-1922 . DOI: 10.1038/ajg.2012.335
This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/3.0
Showing items related by title, author, creator and subject.
Fontes, Ines; Hartikainen, Hanna; Williams, Chris; Okamura, Beth (2017-11-02)
A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease McGhee, David J. M.; Ritchie, Craig W.; Zajicek, John P.; Counsell, Carl E. (2016-06-16)
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Mounsey, Ross B; Mustafa, Sarah; Robinson, Lianne; Ross, Ruth A.; Riedel, Gernot; Pertwee, Roger G.; Teismann, Peter (2015-11)